Acadian Asset Management LLC Forward Pharma A/S Transaction History

Acadian Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$5.06 - $6.15 $11,653 - $14,163	-2,303 Reduced 3.61%	61,468 $356,000
Q4 2021 Feb 10, 2022	SELL	$5.43 - $7.01 $152,148 - $196,420	-28,020 Reduced 30.53%	63,771 $380,000
Q3 2021 Nov 12, 2021	BUY	$5.97 - $17.66 $204,968 - $606,320	34,333 Added 59.75%	91,791 $623,000
Q2 2021 Aug 11, 2021	BUY	$6.77 - $8.6 $75,316 - $95,675	11,125 Added 24.01%	57,458 $495,000
Q3 2020 Nov 09, 2020	BUY	$5.99 - $6.78 $180,586 - $204,403	30,148 Added 186.27%	46,333 $287,000
Q2 2020 Aug 12, 2020	BUY	$5.16 - $7.77 $83,514 - $125,757	16,185 New	16,185 $99,000

Ticker FWP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,091,180
Market Cap $18.2M
Description
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.